sarpogrelate has been researched along with Cardiomegaly in 1 studies
sarpogrelate: structure given in first source
Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sarpogrelate was developed as an antiplatelet agent antagonizing 5-hydroxytryptamine (5-HT) receptors." | 1.31 | The effects of sarpogrelate on cardiomyocyte hypertrophy. ( Harada, M; Hosoya, T; Ikeda, K; Nakao, K; Tojo, K; Tokudome, G, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, K | 1 |
| Tojo, K | 1 |
| Tokudome, G | 1 |
| Hosoya, T | 1 |
| Harada, M | 1 |
| Nakao, K | 1 |
1 other study available for sarpogrelate and Cardiomegaly
| Article | Year |
|---|---|
The effects of sarpogrelate on cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Endothelin-1; Fibroblasts; | 2000 |